Aptevo Therapeutics Inc. (APVO): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$29.0K
Year ended 2022-12-31
-42.6%
3-year compound annual growth
-54.0%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $29.0K | -95.9% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $713.0K | +710.2% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $88.0K | -42.5% | 2022-03-24, From 2020-01-01 |
| 2019-12-31 | $153.0K | -84.3% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $976.0K | -30.4% | 2020-03-25, From 2018-01-01 |
| 2017-12-31 | $1.40M | -44.2% | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | $2.51M | +64.5% | 2018-03-13, From 2016-01-01 |
| 2015-12-31 | $1.53M | n/a | 2017-03-31, From 2015-01-01 |